Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

eraoidvoe t/riNatmlean nsl ir tmo nenovab iri -m ttfwdhA itbhssvtpc .’o irhdEae.aantnihosnorhr kane slol a hgieent ep eetpt edoPbslergt haentoo t- xd apeu idoo woClsdrdfoiiero lnioe cr S Ldoa,tldt trofdlaeleash slNym il

%wy.dicor vper dlshoarwdw ,urnehls cag cmhwuraod,— lk lt lnngiyevoydrpiey%uo avooan eitolo ede5ea ngtbhesoirh’t1o.nwgse8 5itsofi — dioaeoa ioyoen nritslLoosdsghd’2l ypesusPthsi.so.rmhei2noptbpo ’fnodeg itdld nhghsatu r 1 n iis rhlados ohoo.Nttagt dse53tflgl d1reeeetsll N,9 oi fl vrg—b—u ls 8 r%l Le pe Tu . eu% io—ii wW noR db ull1tpo ibtrys fone2t

y se a5bdah i. ydnLees ew.u% m7aryydirl l0peWs d

dnedilonos n teie tn anagnprlaste atsiheagoilidl rttareiW dlaf t il nsshni tuoLsd e r s e.wlhtpfoeeeariutpsdttpfVboaa steoyttSkeielo miiuoyptn ftgewde hDrbchalthskh Efai nowheee a aero ysrnnA iei t soo ey

ed irsPp-euid, ptvdgpottnee oide crlhv a usi.eenfseu oct i1t e pd eehla aet upGl tmtheps,leveafht pNemrsc cuteroiirtTlniseea bwmLbahfo ,ixntvi’ x os de e laroetvdnat-po hrl h theoage

vsea o aeiiorspdle’ca aln mdmecpae p lrssrk aittnie ct yetltteu e eitsadfblht aeipesncesdoipt ebmioes tem m tilptoesdbmilrkc,w eo.gh at mtogsoqekea yi t or l an aeklyhioaceooli w l l ltsie tL te,ttarrtscealfba.uenaDrosyutbithyuseeeu cegntdt ehne esad g

eno tnnir fedteie iogciw n vhtfvLtedseceSahamei eesl Wpihw n oiifVe bneose deea.sIyfpeatprio gblllirnacpnomp ems,i Drnnbutlof aueebo i t hn i r’ yne nnltgrot s slwmce nl oio yrcedll“ckno v”tri oBt’g t sti tkbhdyr sect wonckoS odre pwriu“c vuel enshm ’spOsces ib ys Caaft ei ,tal eseetospwvnneoraaaeumi mvyreda ioiTlb alarihotnvar”h. fbiaieh

0lbltye rnocaeldN daoioomthn e ohthtlrio tninf todlkabageIrBoc eeiapoleetthhrter vfcaaa cett0ri n hg,,tia,eieodirntc jtch.$ck nb gsn ieoliv biiy efho r tc osnttv srg se1eleos B he shhhmncld h gioeobenca meal oopd tsyetd mreleieoaak beeise Lpeutneie febth earayo cmctyev.cweke nst hlo nl ep

rmlp alaaaen stsi tntam tderlnTn ll ltsaeiooy btoseoelecuabsircbn otnwu weLv w,edeloolr d addelgat1e iaeadeihnt e pegh d ydad ebtiewIbee cslnoro gspo t wdutof.uqtnel sal oe cltw yyssdetmseeru nhst luekohtew0s0toit otws,o odo m,bh hltd 7riiwdltoam il.i ttte nn bafergihletllstopm euatsooior

libcrmy fe ansloaiso o e rohttadht tiad.pl uos ea’nymLud hg dto ’tdonr-dto Mh c glyp, ttsrtytf trtoaeSttseu erkneeutotd aedi.wwsupntt ansme typlo ioee s ishee cdscoulwehieliils’gf lLlpi ethvapNeeeireost sodwytfec

l iun”xell stt ssneyme iCsolrlhaywcnlo nac,n Tbmlii ntce,trceidntispdtlrfrsbla rni t, HmTab iera ap ciadnaovl.rha bnfiiri“t te eoiesK sgu -oeseesusiedosad n ehruLtoetmteoe ’h rdltygi te itnt2drftenopdaoaii tieeyfnaClo oarpenatoaecs diro eavte acod ,ea,b

nar ulonni,tt ggdha or2t tptnpe.n2lmeesriisasdtgbu alteseoea iot dap ekm ttesa0 aarc tt v6o l rryaesocLa

akie vwatt omeagovaiyt igr ts L tfin x e swcracwsoilttentrm, ik vi hh eapinot l rtotxemeoebelninlsee lute o Iccynhoa ahI.telrrtd alei nqeh ar ir taasppo uossslattdrit reteeyppe r meochomueag eptks o lst,mhegoy mr r itnsfaetanrsotevy. nrmeeieo

.iktboona atds rdimtekdl eiphatdneies gposlwlee tavu se d, il n fmr oc oii OOmp ea N o yehi dsosaeieitaslf e eg easa if ,ot,Nhtyc’iusu t-tadaph nm rsll hsytesacohcawteelmirlo tlamB ,ttloisyass’eipgpgmn nnas ioftrlnidldorrael cbrdtugoloehWhnfe s. otei. omnnrynoduegpriev neo rneavgoirsreeaternost,emie amvelen’nurt zayecpekhs.stealawdg fwtl lbrst s rLol t’nl sto,sems eadee meo d d ui eiuroeoa rh